Veritas Capital ended talks with Carlyle Group Inc (CG.O) to buy a 50% stake in private healthcare technology firm Cotiviti Inc on valuation grounds, a source familiar with the matter said. Carlyle wasn’t ready to stick to the valuation that had previously been discussed in the current market conditions and submitted a revised bid in recent days, which Veritas rejected, the source said. In February, Reuters reported that Carlyle was in talks to buy a portion of Cotiviti from Veritas Capital at a valuation of around $15 billion.
Read the full article: Veritas, Carlyle End Talks on Cotiviti Stake Sale //
Source: https://www.reuters.com/markets/deals/veritas-carlyle-end-talks-cotiviti-stake-sale-source-2023-04-12